+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Telepharmacy - Global Strategic Business Report 2026

  • PDF Icon

    Report

  • 144 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6110237
The global market for Telepharmacy was valued at US$10.5 Billion in 2025 and is projected to reach US$46.1 Billion by 2032, growing at a CAGR of 23.6% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Telepharmacy Market - Key Trends & Drivers Summarized

How is Telepharmacy Bridging Gaps in Healthcare Access?

Telepharmacy enables remote delivery of pharmaceutical services - such as medication dispensing, counseling, and therapy monitoring - via digital platforms. Pharmacies use video calls, secure messaging, and robotic dispensing units to serve patients in rural or underserved areas lacking brick-and-mortar pharmacies. Cloud-based pharmacy management systems facilitate prescription verification, electronic health records integration, and adherence tracking. The move from pilot projects to fully integrated telepharmacy networks reflects a shift in how pharmacies are viewed - not just as physical dispensaries, but as healthcare delivery nodes accessible virtually 24/7.

What Technological Advances Are Driving This Evolution?

AI-powered medication review tools now assist pharmacists in identifying drug-drug interactions and personalized dosage adjustments. Automated dispensing kiosks and tele-robotic arms allow remote technicians to oversee safe fulfillment under pharmacist supervision. Tele-pharmaceutical care apps offer features like refill reminders, virtual pill-swallowing coaching, and biometric monitoring for chronic conditions. Blockchain and e-prescription systems improve prescription security and interoperability, while real-time translation modules support non-native speakers in underserved regions. These innovations are reshaping traditional workflow, enabling more efficient, high-quality patient support.

Which Stakeholder Needs Are Steering Telepharmacy Adoption?

Patients with mobility limitations or chronic diseases benefit from home delivery and remote counseling - reducing travel burden and enhancing medication adherence. Employers and insurers see telepharmacy as a way to ensure continuity of care while lowering costs tied to emergency visits. Pharmacies facing workforce shortages leverage telepharmacy to redistribute pharmacist time, support after-hours service, and expand service coverage. Health systems and community hospitals incorporate telepharmacy to comply with regulatory requirements and offer electronic medication reconciliation in rural clinics or during night shifts, improving patient safety in remote settings.

What Is Propelling the Telepharmacy Market Forward?

The growth in the telepharmacy market is driven by several factors including regulatory easing on remote dispensing and e-prescriptions, increased investment in pharmacy automation hardware, rising chronic disease prevalence requiring ongoing medication management, and patient preference for convenient, virtual care. The convergence of telehealth platforms with pharmacy benefit managers (PBMs) enables integrated services and enhanced adherence tracking. Technology companies are expanding into pharmacy services, and pharmacists are gaining provider status in some regions - creating a favorable environment for telepharmacy growth.

Report Scope

The report analyzes the Telepharmacy market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Services (Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services, Refill Authorization for Prescription Drugs Services); Deployment (On-Premise Deployment, Web-based Deployment, Cloud-based Deployment).
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Patient Counseling Services segment, which is expected to reach US$23.8 Billion by 2032 with a CAGR of a 25%. The Remote Dispensing Services segment is also set to grow at 23.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $3.1 Billion in 2025, and China, forecasted to grow at an impressive 22.5% CAGR to reach $7.8 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Telepharmacy Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Telepharmacy Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Telepharmacy Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Advanced Rx Management, Alto Pharmacy, AMN Healthcare, Cardinal Health, CarepathRx and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Telepharmacy market report include:

  • Advanced Rx Management
  • Alto Pharmacy
  • AMN Healthcare
  • Cardinal Health
  • CarepathRx
  • Cisco Systems
  • Comprehensive Pharmacy Services (CPS)
  • Locke Bio
  • McKesson Ventures
  • Medication Review Inc.
  • MedTel Services
  • North West TelePharmacy Solutions
  • Nurx
  • One Touch Video Chat
  • OSP Labs (telepharmacy solutions)
  • PDS (Pharmacy Delivery Systems)
  • PharmD Live
  • PipelineRx
  • Truepill
  • Zane Networks

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Telepharmacy - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Medication Access in Remote and Underserved Areas Throws the Spotlight on Telepharmacy
  • Growth in Chronic Disease Management and Medication Adherence Programs Drives Virtual Pharmacy Adoption
  • Integration with EHR and Telemedicine Platforms Strengthens the Business Case for Pharmacist-Led Virtual Consults
  • Post-COVID Acceleration of Digital Health Acceptance Spurs Long-Term Demand for Remote Pharmacy Services
  • Expansion of Mail-Order and E-Prescription Models Enables Seamless Fulfillment Through Telepharmacy Channels
  • Increased Use of Video Counseling and Refill Management Tools Improves Patient Engagement and Compliance
  • Technology Integration with Smart Pill Dispensers and Medication Tracking Apps Expands Ecosystem Reach
  • Rise of D2C Health Startups Creates Strategic Demand for API-Enabled Telepharmacy Infrastructure
  • Growth of Specialty Pharmacy Services Supports Virtual Counseling for Complex Medication Regimens
  • Cost Savings for Healthcare Systems Fuel Adoption of Telepharmacy in Rural and Institutional Settings
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Telepharmacy Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Telepharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World 8-Year Perspective for Telepharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2026 & 2032
  • Table 4: World Recent Past, Current & Future Analysis for Patient Counseling Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 5: World 8-Year Perspective for Patient Counseling Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 6: World Recent Past, Current & Future Analysis for Remote Dispensing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 7: World 8-Year Perspective for Remote Dispensing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Drug Therapy Monitoring Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World 8-Year Perspective for Drug Therapy Monitoring Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 10: World Recent Past, Current & Future Analysis for Refill Authorization for Prescription Drugs Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 11: World 8-Year Perspective for Refill Authorization for Prescription Drugs Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 12: World Recent Past, Current & Future Analysis for On-Premise Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 13: World 8-Year Perspective for On-Premise Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Web-based Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World 8-Year Perspective for Web-based Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 16: World Recent Past, Current & Future Analysis for Cloud-based Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 17: World 8-Year Perspective for Cloud-based Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 18: USA Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 19: USA 8-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2026 & 2032
  • Table 20: USA Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 21: USA 8-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2026 & 2032
CANADA
  • Table 22: Canada Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 23: Canada 8-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2026 & 2032
  • Table 24: Canada Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 25: Canada 8-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2026 & 2032
JAPAN
  • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 26: Japan Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 27: Japan 8-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2026 & 2032
  • Table 28: Japan Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 29: Japan 8-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2026 & 2032
CHINA
  • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 30: China Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 31: China 8-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2026 & 2032
  • Table 32: China Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 33: China 8-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2026 & 2032
EUROPE
  • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 34: Europe Recent Past, Current & Future Analysis for Telepharmacy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 35: Europe 8-Year Perspective for Telepharmacy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2026 & 2032
  • Table 36: Europe Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 37: Europe 8-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2026 & 2032
  • Table 38: Europe Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 39: Europe 8-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2026 & 2032
FRANCE
  • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 40: France Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 41: France 8-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2026 & 2032
  • Table 42: France Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 43: France 8-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2026 & 2032
GERMANY
  • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 44: Germany Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 45: Germany 8-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2026 & 2032
  • Table 46: Germany Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 47: Germany 8-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2026 & 2032
ITALY
  • Table 48: Italy Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 49: Italy 8-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2026 & 2032
  • Table 50: Italy Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 51: Italy 8-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2026 & 2032
UNITED KINGDOM
  • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 52: UK Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 53: UK 8-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2026 & 2032
  • Table 54: UK Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 55: UK 8-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2026 & 2032
REST OF EUROPE
  • Table 56: Rest of Europe Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 57: Rest of Europe 8-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2026 & 2032
  • Table 58: Rest of Europe Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 59: Rest of Europe 8-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2026 & 2032
ASIA-PACIFIC
  • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • Table 60: Asia-Pacific Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 61: Asia-Pacific 8-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2026 & 2032
  • Table 62: Asia-Pacific Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 63: Asia-Pacific 8-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2026 & 2032
REST OF WORLD
  • Table 64: Rest of World Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 65: Rest of World 8-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2026 & 2032
  • Table 66: Rest of World Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 67: Rest of World 8-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2026 & 2032
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Advanced Rx Management
  • Alto Pharmacy
  • AMN Healthcare
  • Cardinal Health
  • CarepathRx
  • Cisco Systems
  • Comprehensive Pharmacy Services (CPS)
  • Locke Bio
  • McKesson Ventures
  • Medication Review Inc.
  • MedTel Services
  • North West TelePharmacy Solutions
  • Nurx
  • One Touch Video Chat
  • OSP Labs (telepharmacy solutions)
  • PDS (Pharmacy Delivery Systems)
  • PharmD Live
  • PipelineRx
  • Truepill
  • Zane Networks

Table Information